Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Innovative Institute of Chinese Medicine and Pharmacy
Qingqing Liu has not added Biography.
If you are Qingqing Liu and would like to personalize this page please email our Author Liaison for assistance.
Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti-Acute Myeloid Leukemia Efficacy In Vitro and In Vivo.
Molecular pharmacology Nov, 2019 | Pubmed ID: 31462456
Targeting Engineered Nanoparticles for Breast Cancer Therapy.
Pharmaceutics Nov, 2021 | Pubmed ID: 34834243
Anti-migratory Properties of Cryoprotective Isoliquiritigenin-zein Phosphatidylcholine Nanoparticles Prevent Triple-negative Breast Cancer through PI3K-mTOR and MMP2/9 Pathways.
Current medicinal chemistry Nov, 2023 | Pubmed ID: 37936460
Chengdu University of Traditional Chinese Medicine
Zhihao Sun1,2,
Wenqiao An2,
Taiping He2,
Qingqing Liu2,
Ziming Wang2,
Pengmei Guo2,
Sanyin Zhang2,3
1School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine,
2Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine,
3Research Institute of Integrated TCM & Western Medicine, Chengdu University of Traditional Chinese Medicine
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved